FDA
approval
· 2022-04-28
FDA Approved: PIRFENIDONE — Original Application (Sandoz Inc)
Summary
The FDA approved Sandoz Inc's original application for a generic pirfenidone product for treatment of idiopathic pulmonary fibrosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for PIRFENIDONE (PIRFENIDONE)